XHKG
1717
Market cap231mUSD
Oct 09, Last price
1.02HKD
1D
0.00%
1Q
-21.54%
Jan 2017
-66.99%
IPO
-79.27%
Name
Ausnutria Dairy Corp Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ausnutria Dairy Corporation Ltd, an investment holding firm, is primarily involved in the entire lifecycle of infant formula and other dairy products, encompassing research and development, milk sourcing, processing, manufacturing, packaging, marketing, and distribution. Its operations are divided into two main divisions: Dairy and Related Products, and Nutrition Products. The company markets cow milk-based formula products under brand names such as Allnutria, Hyproca Hollary, Hyproca Hypure, Neolac, and Puredo. Additionally, its goat milk-based infant formula is sold under the Kabrita brand. Ausnutria also functions as an original equipment manufacturer (OEM) for formula milk powder products. Beyond dairy, it manufactures and distributes various nutrition products, develops and sells probiotic items, and offers financing solutions. Its global footprint spans the People's Republic of China, the European Union, Southeast Asia, Australia, New Zealand, the Middle East, North and South America, and other international markets. Established in 2003, Ausnutria Dairy Corporation Ltd is headquartered in Sheung Wan, Hong Kong, and operates as a subsidiary of HongKong Jingang Trade Holding Company Limited.
Related entities
Subsidiaries (2)
Ausnutria B.V.
Ausnutria Operations B.V.
Key people
Shixiu Han
Non-Executive Chairman of the Board · since 2024
Chief Financial Officer · since 2023
Ruijie Yang
Chief Financial Officer · since 2025
Jeroen Kiers
Chief Executive Officer of Ausnutria BV · since 2019
Chief Compliance Officer · since 2023
Zhijian Ren
Chief Executive Officer, Executive Director · since 2023
Bartle van der Meer
Executive Director · since 2023
Zhi Zhang
Executive Director · since 2023
Zhiyong Dai
Executive Director of Ausnutria China · since 2013
Shenhui Deng
Vice President of the Group in China, General Manager of the Nengliduo Business Unit, Chief Operating Officer of the Group in China · since 2016
Nicolette Diekema
Quality Assurance Director of Ausnutria BV · since 2020
Froukje Dijkstra
Chief Operating Officer of Ausnutria BV · since 2012
Wouter Engbers
ICT Director of Ausnutria B.V · since 2021
Haoru Hong
Secretary of the China Regional Management Committee, Assistant to the Chief Executive Officer of the Group
Fangming Hu
Vice President of the Group in China, General Manager of the Supply Chain Branch, Vice President of Ausnutria Research Institute
Mark Kaptein
Sales Director of Ausnutria BV · since 2020
Yimin Li
Vice President of the Group in China, General Manager of Kabrita's Business Unit · since 2020
Yuehui Liu
Secretary of the Party Committee, Chairman of the Labor Union of the Group in China · since 2020
Yubiao Liu
Vice President of the Group in China, General Manager of Hyprochem Biotechnology Co., Ltd · since 2020
Xuecong Liu
Vice President of China, Vice President of Ausnutria Research Institute of the Group
Headquarters & legal address
c/o Codan Trust Company (Cayman) Limited, Cricket Square, Hutchins Drive, P.O. Box 268
Grand Cayman KY1-1111
KY
Grand Cayman KY1-1111
KY
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||